心力衰竭治疗药物新进展  

The new progress of heart failure therapy

作　　者：许旭新[1] 

机构地区：[1]揭阳市人民医院,广东揭阳522000

出　　处：《基层医学论坛》2011年第1期79-81,共3页The Medical Forum

摘　　要：目的对传统心力衰竭的药物治疗有新的转变和新的认识。方法参阅相关文献,对之综合、分析和归纳。结果洋地黄类、血管紧张素转换酶抑制剂、β受体阻滞剂、血管紧张素受体拮抗剂和醛固酮拮抗剂(螺内酯)等是治疗心力衰竭中较为理想的药物。结论心力衰竭治疗应从最新模式———神经内分泌综合调控模式进行。Objective To investigate new change and awareness to traditional heart failure drug treatment.Methods The related literature were analyzed and summarized.Results Digitalis class,angiotensin-converting enzyme inhibitor,β-blockers,angiotensin receptor blocker and aldosterone antagonist（spironolactone）were ideal in the treatment of heart failure drug.Conclusion The new treatment model of heart failure should be the treatment of neuroendocrine comprehensive regulation.

关 键 词：心力衰竭药物 洋地黄类 血管紧张素转换酶抑制剂 Β受体阻滞剂 血管紧张素受体拮抗剂和醛固酮拮抗剂 神经内分泌 

分 类 号：R541.6[医药卫生—心血管疾病]